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Background: The extent to which moderate over-
weight (body mass index [BMI], 25.0-29.9 [calculated
as weight in kilograms divided by height in meters
squared]) and obesity (BMI,30.0) are associated with
increased risk of coronary heart disease (CHD) through
adverse effects on blood pressure and cholesterol levels
is unclear, as is the risk of CHD that remains after these
mediating effects are considered.
Methods: Relative risks (RRs) of CHD associated with
moderate overweight and obesity with and without ad-
justment for blood pressure and cholesterol concentra-
tions were calculated by the members of a collaboration
of prospective cohort studies of healthy, mainly white per-
sons and pooled by means of random-effects models (RRs
for categories of BMI in 14 cohorts and for continuous
BMI in 21 cohorts; total N=302 296).
Results: A total of 18 000 CHD events occurred during
follow-up. The age-, sex-, physical activity–, and smoking-
adjusted RRs (95% confidence intervals) for moderate
overweight and obesity compared with normal weight
were 1.32 (1.24-1.40) and 1.81 (1.56-2.10), respec-
tively. Additional adjustment for blood pressure and cho-
lesterol levels reduced the RR to 1.17 (1.11-1.23) for mod-
erate overweight and to 1.49 (1.32-1.67) for obesity. The
RR associated with a 5-unit BMI increment was 1.29 (1.22-
1.35) before and 1.16 (1.11-1.21) after adjustment for
blood pressure and cholesterol levels.
Conclusions: Adverse effects of overweight on blood pres-
sure and cholesterol levels could account for about 45%
of the increased risk of CHD. Even for moderate over-
weight, there is a significant increased risk of CHD in-
dependent of these traditional risk factors, although con-
founding (eg, by dietary factors) cannot be completely
ruled out.
Arch Intern Med. 2007;167(16):1720-1728
M ODERATE OVERWEIGHT(body mass index[BMI], 25.0-29.9 [cal-culated as weight in ki-lograms divided by
height in meters squared]) and obesity
(BMI, 30.0) (both henceforth called
“overweight”) are highly prevalent in
Western populations. Nearly two-thirds of
US adults1 and 60% of Australians2 are
overweight, and increasing trends are ap-
parent throughout the world.3 Obesity is
clearly associated with increased mortal-
ity4,5 and adverse health outcomes, includ-
ing coronary heart disease (CHD).6
Because of the high prevalence of over-
weight and the expected future in-
creases, it is essential to gain precise in-
sight into the consequences of overweight
for health and into the metabolic path-
ways that link the two. This study inves-
tigated the relationship between over-
weight and CHD and, specifically, the
extent to which this relationship is medi-
ated by adverse effects of overweight on
blood pressure and cholesterol levels. This
research is relevant to clinical practice be-
cause it provides an indication about the
excess risk of CHD in overweight people
that would persist after optimal treat-
ment for hypertension and hypercholes-
terolemia was established. Furthermore,
it addresses the question whether to in-
corporate overweight as an additional
modifiable risk factor incommonlyusedrisk
stratification schemes such as Adult Treat-
ment Panel III or Framingham.7,8 Accord-
ing to Adult Treatment Panel III, the inde-
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pendent component of risk not
mediated through the major risk fac-
tors has not been quantified. Re-
cently, cohort investigations have
demonstrated that overweight is re-
lated to CHD apart from its associa-
tion with traditional risk factors such
as blood pressure and cholesterol lev-
els.9,10 Another recent publication
showed that the association be-
tween overweight and death from ath-
erosclerotic cardiovascular causes was
attenuated to statistically nonsignifi-
cant levels after adjustment for blood
pressure, cholesterol level, and blood
glucose level.11 An analysis based on
many prospective cohort studies
would add to the available evidence.
The present report describes a
meta-analysis of the associations be-
tween overweight and risk of CHD
for 302 296 healthy persons, mainly
white. We report pooled estimates of
relative risk (RR) adjusted in a stan-
dardized way from 21 prospective co-
hort studies that participated in a
worldwide collaboration. The main
outcome measure of the analysis was
the age-, sex-, physical activity–, and
smoking-adjusted RR of CHD, with
and without adjustment for blood
pressure and cholesterol levels.
METHODS
DATA SOURCES
Studies were identified by regularly
checking the PubMed and MEDLINE da-
tabases, by examination of the refer-
ence lists of identified articles, and via
suggestions by colleagues. An addi-
tional literature search was performed
in MEDLINE (1996-2005) by using the
following search strategy: obesity, body
mass index, BMI, or overweight in either
the title or in the Medical Subject Head-
ing (MeSH) and either coronary heart dis-
ease in the title or coronary disease in
MeSH, plus either prospective or cohort.
STUDY SELECTION
Eligible studies were prospective co-
hort studies conducted in healthy popu-
lations that consisted mainly of white
persons for whom RRs of BMI or over-
weight for total incidence or mortality
from CHD had been reported. We iden-
tified 70 studies that met our inclusion
criteria; we were able to contact 62 in-
vestigators, and 31 of them agreed to col-
laborate (44% of the 70 eligible cohorts
[an appendix listing the studies that were
not included is available at the authors’
Web site: http://www.rivm.nl/bibliotheek
/digitaaldepot/appendiximd06.htm]).
For the present report, it was necessary
that RRs from the cohort be available
with multiple adjustments for age, sex,
physical activity, and smoking, both with
and without simultaneous adjustment
for blood pressure and cholesterol lev-
els. Of the complete collaboration, 21 co-
horts fulfilled this criterion.
DATA EXTRACTION
We requested that investigators from the
participating cohort studies calculate RRs
and 95% confidence intervals (CIs) with
systematic univariate and multiple ad-
justments for age, sex, physical activ-
ity, smoking, blood pressure, and cho-
lesterol levels. To minimize the amount
of work and maximize participation, in-
vestigators could calculate the RRs of
CHD in a way similar to that used in the
original articles, eg, for the same BMI cat-
egories and follow-up time.
An appendix (available at the au-
thors’ Web site) presents the methods that
were used in the original studies to de-
fine smoking habits, physical activity,
blood pressure, and blood cholesterol
level, and whether BMI was analyzed as
a continuous variable or in categories.
One cohort (Nurses’ Health Study) used
BMI based on self-reported weight and
height, instead of measurements.
Adjustment for smoking was gener-
ally conducted by inclusion of dummy
variables to indicate never-smokers, ex-
smokers, and current smokers in the
multiple regression model. For blood
pressure, the majority of studies (n=15)
used systolic pressure, and for blood cho-
lesterol concentrations, total choles-
terol (n=19). Other measures were, for
instance, diastolic blood pressure and el-
evated total cholesterol concentrations
(yes or no). Physical activity was pre-
dominantly defined by means of vari-
ous categories of intensity, but there was
considerable diversity between studies.
Descriptive statistics for each cohort (eg,
mean age, follow-up time, mean BMI in
each category, number of persons, and
cases of CHD per category) and the defi-
nition of the variables were checked by
the original investigators.
DATA SYNTHESIS
Dummy variables indicated whether ad-
justments were made for smoking, physi-
cal activity, blood pressure, and choles-
terol levels. The RRs were plotted to
visualize variation in results between
studies. Relative risks with equivalent ad-
justments were pooled by means of a
random effects model12 and were calcu-
lated for the categories moderate over-
weight (BMI, 25.0-29.9) and obesity
(BMI,30.0), as compared with the ref-
erence category (“normal” weight; BMI,
18.5-24.9). Studies were selected in
which the foregoing definition of the
overweight categories was used. In this
selection, the lower limit of the normal
weight category varied somewhat be-
tween cohorts (see the appendix at the
author’s Web site). Therefore, the meta-
analysis was also performed in subsets
with equal lower limits. These analyses
showed that the percentage decrease in
RR after adjustment for blood pressure
and cholesterol levels was similar (data
not shown). The final number of co-
horts for the analyses of the categories
moderate overweight and obesity was 14.
We also calculated risk of CHD by
using BMI as a continuous variable, eg,
risk per 5-unit increase in BMI. In this
case, if individual studies had provided
only RRs for categories of BMI, we trans-
formed the independent variable to its
continuous form for each set of adjust-
ments by applying the method of Green-
land and Longnecker,13 but using num-
ber of cases as observed rather than their
fitted values.14 Consequently, more co-
horts were available for these analyses
(n=21) than for the analyses of catego-
ries of BMI.
Statistical significance of the change
in RR after adjusting for blood pressure
and cholesterol level was assessed by
means of meta-regression analysis (in
which results stemming from a single
study shared the same random effect).
The analyses were repeated for cohorts
with measured BMI (instead of BMI based
on self-reported weight and height of the
participants) and cohorts in which mea-
sures for blood pressure and cholesterol
concentrations were systolic blood pres-
sure and total cholesterol concentra-
tions (instead of, eg, diastolic blood pres-
sure). Heterogeneity of RRs between
studies was examined by 2 tests. All
analyses were performed with the MIXED
procedure in SAS statistical software, ver-
sion 9 (SAS Institute Inc, Cary, NC).15-36
RESULTS
CHARACTERISTICS
OF COHORTS
Table 1 presents characteristics of
the study populations, which in-
cluded a total of 302 296 persons.
Most studies used either mortality
from CHD or incidence of CHD
(both fatal and nonfatal events) as
their end point. A total of 18 000
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Table 1. Characteristics of Studies Included in the Analysis
Study
Sex,
% M
Age
Range, y
Baseline
Year(s)
Median
or Mean
Follow-up,
y
Current
Smoker, %
No. Available
for Analysis
No. of
Cases End Point
Australian National Heart
Foundation Risk Factor
Prevalence Study15
49 20-70 1989-1990 8.3 24 9099 76 Death from CHD: ICD-9 codes 410-414
Caerphilly Cohort
Study16,17a
100 47-67 1984-1988 12 44 2160-2357 398 Fatal and nonfatal events: death from
CHD; clinical nonfatal (definite
acute) MI; electrocardiographic MI
Dubbo Study of Australian
Elderly18a
44 60-94 1988 13 15 2805 968 Fatal and nonfatal events:
hospitalization or death: ICD-9-CM
codes 410-414
Finnish Mobile Clinic
Health Examination
Survey19
53 30-69 1967-1972 22 34 30 765 3319 Death from CHD: ICD-8 codes 410-414
Fletcher Challenge20 72 20-89 1992 4.8 24 10 201 110 Death from CHD
Italian Rural Areas21a 100 40-59 1960 35 61 1622 214 Death from CHD: definite fatal MI;
other forms of fatal ischemia;
sudden death from CHD
Kuopio Ischaemic Heart
Disease Risk Factor
Study22
100 42-61 1984-1989 10.6 31 1597 155 Fatal and nonfatal events: definite and
probable acute MI; prolonged chest
pain episodes
Malmo¨ Preventive Project23 100 27-61 1974-1984 17.7 49 22 025 1727 Fatal and nonfatal events: acute MI
(ICD code 410); death from chronic
CHD (ICD codes 412 and 414)
Melbourne Collaborative
Cohort Study24
41 27-75 1990-1994 5.6 11 41 119 323 Death from CHD
Multifactor Primary
Prevention Study,
Go¨teborg25
100 47-55 1970-1973 22 50 7371 1688 Fatal and nonfatal events: death from
CHD (ICD-8/9 codes 410-414);
nonfatal MI
NHANES I Epidemiologic
Follow-up Study26
44 25-74 1971-1975 20 45 5139/5078 543 Death from CHD: ICD-9 codes
410-414.9
Nijmegen Cohort Study27 48 20-52 1977-1978 18 58 5898 268 Fatal and nonfatal events: MI; angina
pectoris
Norwegian Counties
Study28
51 35-49 1974-1978 26 45 43 896 1564 Death from CHD: ICD-8/9 codes
410-414, ICD-10 codes I21-I25;
sudden deaths (ICD-8 codes 782.4
and 795; ICD-9 codes 798.1-798.2;
ICD-10 code R96)
Nurses’ Health Study29b 0 34-59 1980 20 28 76 615 1996 Fatal and nonfatal events: death from
CHD; nonfatal MI; sudden death
within 1 h of onset of symptoms in
women with no plausible cause
other than CHD
PRIME Study30a 100 50-59 1991-1993 5 28 9757 317 Fatal and nonfatal events: MI; death
from CHD; angina pectoris
Rome Railroad Cohort31a 100 40-59 1962 25 66 726 88 Death from CHD: definite fatal MI;
sudden death from
CHD; cases judged of CHD origin
although manifested only as heart
failure, arrhythmia, and blocks
Scottish Heart Health
Study32
51 40-59 1984-1987 7.6 39 10 262 171 Fatal and nonfatal events: MI; coronary
artery surgery; death from CHD
US Railroad Cohort31a 100 40-59 1957-1959 25 60 2415 481 Death from CHD: definite fatal MI;
sudden death from CHD; cases
judged of CHD origin although
manifested only as heart failure,
arrhythmia, and blocks
Ventimiglia di Sicilia Heart
Study33a
43 20-69 1989 8 17 835 8 Death from CHD: defined MI; sudden
death
Whitehall Study34,35 100 40-64 1967-1969 33 41 17 475 3503 Death from CHD: ICD-8 codes 410-414
Zutphen Elderly Study36 100 64-84 1985 10.3 33 575 83 Death from CHD: ICD-9 codes 410-414
Abbreviations: CHD, coronary heart disease; ICD, International Classification of Disease (-8, -9, and -10 indicate the revision number; CM, Clinical Modification);
MI, myocardial infarction; NHANES, National Health and Nutrition Examination Survey; PRIME, Prospective Epidemiological Study of Myocardial Infarction.
aNo results available for both the categories moderate overweight (body mass index, 25.0-29.9 [calculated as weight in kilograms divided by height in meters
squared]) and obesity (body mass index,30.0).
bBody mass index based on self-report of the participants.
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CHD events were observed during
follow-up. We were able to extend
follow-up for some studies beyond
that reported in the original ar-
ticles. Table 1 presents the data as
used in the present analysis.
RRs FOR MODERATE
OVERWEIGHT AND OBESITY
Figure 1 and Figure 2 present the
RRs of CHD for the separate co-
horts for categories of moderate
overweight and obesity, adjusted for
age, sex, physical activity, and smok-
ing, with and without adjustment
for blood pressure and cholesterol
levels. In all individual studies, the
RR decreased after adjustment for
blood pressure and cholesterol con-
centrations.
Table 2 presents pooled RRs of
CHD for categories of BMI. After ad-
justment for age, sex, physical ac-
tivity, and smoking, moderate over-
weight was associated with an RR of
1.32 (95% CI, 1.24-1.40) and obe-
sity with an RR of 1.81 (95% CI,
1.56-2.10). Additional adjustment
for blood pressure and cholesterol
levels statistically significantly re-
duced the RR to 1.17 (95% CI, 1.11-
1.23) for moderate overweight and
1.49 (95% CI, 1.32-1.67) for obe-
sity. This corresponds to a decrease
in excess risk of 47% for moderate
overweight and 40% for obesity, ie,
[(1.81−1.49)/(1.81−1)]100=40%.
The RRs were similar for studies
in which BMI was measured (n=13)
instead of based on self-reported
weight and height, and for studies
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Figure 1. Relative risks of coronary heart disease for moderate overweight (body mass index [calculated as weight in kilograms divided by height in meters
squared], 25.0-29.9) adjusted for age, sex, smoking, and physical activity (A) and additionally adjusted for blood pressure and cholesterol concentrations (B),
sorted by descending study size (reflected by the size of the square). Limit lines indicate the 95% confidence interval. NHANES indicates National Health and
Nutrition Examination Survey.
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in which BMI was measured and ad-
justments were made for systolic
blood pressure and total choles-
terol levels (n=11; instead of other
indicators such as diastolic blood
pressure [the appendix at the au-
thors’ Web site] shows which mea-
sures of blood pressure and choles-
terol levels were used]). In the latter
subset of studies, the risk of CHD de-
creased statistically significantly by
50% for moderate overweight and
43% for obesity after additional ad-
justment for blood pressure and cho-
lesterol levels.
RR ASSOCIATED WITH A
5-UNIT INCREASE IN BMI
When BMI was analyzed as a con-
tinuous variable, the age-, sex-,
physical activity–, and smoking-
adjusted RR associated with a 5-unit
increase was 1.29 (95% CI, 1.22-
1.35; n=21; Table3). After exclud-
ing participants with a BMI less than
20, this RR was similar (n=6 stud-
ies, not shown). The range be-
tween studies was 0.95 to 1.73. Ad-
ditional adjustment for blood
pressure and cholesterol level low-
ered the excess risk by 45% to 1.16
(95% CI, 1.11-1.21; range, 0.83-
1.87). Significant heterogeneity ex-
isted between studies both with and
without adjustment for blood pres-
sure and cholesterol concentra-
tions (P.001).
COMMENT
In this large meta-analysis, involv-
ing 302 296 participants worldwide
and 18 000 CHD events during fol-
low-up, a 5-unit increment in BMI
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Figure 2. Relative risks of coronary heart disease for obesity (body mass index [calculated as weight in kilograms divided by height in meters squared],30.0)
adjusted for age, sex, smoking, and physical activity (A) and additionally adjusted for blood pressure and cholesterol concentrations (B), sorted by descending study
size (reflected by the size of the square). Limit lines indicate the 95% confidence interval. NHANES indicates National Health and Nutrition Examination Survey.
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was associated with a 29% increase
in risk of CHD and, after additional
adjustment for blood pressure and
cholesterol levels, with a 16% in-
creased risk. Hence, the present study
indicates that adverse effects of over-
weight on blood pressure and cho-
lesterol levels could account for about
45% of the increased risk of CHD,
and that there is still a significantly
increased risk of CHD that is inde-
pendent of these effects.
The strength of our analysis lies
in the large number of cohorts and
the systematic adjustments for rel-
evant variables. It is clearly shown
that adjusting for blood pressure and
cholesterol decreases the estimated
RR of CHD substantially. This was
the case in all studies, despite the ob-
served heterogeneity in RRs. Meta-
regression analysis suggests that
causes of heterogeneity are the age
of the population and the fol-
low-up time, but not, for example,
the end point that was used (fatal
and nonfatal incidence vs mortality
of CHD) (data not shown). We did
not exclude the first years of fol-
low-up in our analysis to account for
undiagnosed preexisting disease that
may cause weight loss and death,
leading to a J-shaped BMI-mortal-
ity curve. Previous research showed
that this effect of excluding early
deaths is only marginal.37 In gen-
eral, publication bias, ie, less fre-
quent publication of studies with ab-
sent or negative associations between
BMI and CHD, could have in-
creased the apparent RR. An indi-
cation for the absence of publica-
tion bias (as suggested by a funnel
plot; not shown) is that studies with
higher estimates of RR were not
overrepresented among the studies
with low precision (ie, the smaller
studies). Furthermore, the deci-
sion to participate in the collabora-
tion seemed to depend merely on
practical issues, such as time needed
to conduct the analyses, and not on
the actual results of a study. The ma-
jority of the eligible studies not in-
cluded in our analysis also re-
ported positive associations between
moderate overweight and obesity
and the risk of CHD, although the
results were not always statistically
significant. (An overview of these re-
sults from the literature is available
at the authors’ Web site).
The present study has 2 impor-
tant implications. First, even mod-
erate overweight is associated with
increased risk of CHD (for obesity
Table 2. Relative Risks (RRs) of Coronary Heart Disease for Moderate Overweight and Obesity Compared With Normal Weighta
With and Without Adjustments for Blood Pressure and Cholesterol Levels
Selection (No. of Studies)
RR (95% CI) for
Moderate Overweight
P Value for
Heterogeneityb
RR (95% CI)
for Obesity
P Value for
Heterogeneityb
Adjusted for Age, Sex, Physical Activity, and Smoking
All studies (14) 1.32 (1.24-1.40) .007 1.81 (1.56-2.10) .001
BMI measured (13) 1.29 (1.22-1.37) .12 1.72 (1.52-1.96) .001
BMI measured, systolic blood pressure and
total cholesterol (11)c
1.32 (1.24-1.40) .26 1.69 (1.45-1.97) .001
Additionally Adjusted for Blood Pressure and Cholesterol
All studies (14) 1.17 (1.11-1.23)d .15 1.49 (1.32-1.67)d .001
BMI measured (13) 1.14 (1.09-1.18)d .88 1.41 (1.31-1.53)d .11
BMI measured, systolic blood pressure and
total cholesterol (11)c
1.16 (1.11-1.21)d .96 1.39 (1.26-1.53)d .10
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CI, confidence interval.
aFor each study’s definition of normal weight, see the appendix available at http://www.rivm.nl/bibliotheek/digitaaldepot/appendiximd06.htm; moderate over-
weight, BMI of 25.0 to 29.9; obesity, BMI of 30.0 or more.
bP value for heterogeneity in RR between studies.
cFor these studies, the RRs are adjusted for systolic blood pressure (instead of other indicators such as diastolic blood pressure) and total cholesterol concen-
trations (instead of other indicators of cholesterol).
dP .001 for difference in RR with and without adjustment for blood pressure and cholesterol level.
Table 3. Relative Risks (RRs) of Coronary Heart Disease per 5-Unit Increase in BMI With and Without Adjustments
for Blood Pressure and Cholesterol Levels
Selection (No. of Studies)
RR (95% CI)
Adjusted for Age,
Sex, Physical Activity,
and Smoking
P Value for
Heterogeneitya
RR (95% CI)
Additionally Adjusted
for Blood Pressure
and Cholesterol
P Value
Heterogeneitya Differenceb
All studies (21) 1.29 (1.22-1.35) .001 1.16 (1.11-1.21) .001 .001
BMI measured (20) 1.27 (1.21-1.33) .001 1.15 (1.11-1.19) .04 .001
BMI measured, systolic blood pressure
and total cholesterol (15)c
1.28 (1.20-1.36) .001 1.15 (1.11-1.20) .04 .001
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CI, confidence interval.
aP value for heterogeneity in RR between studies.
bP value for difference in RRs with and without adjustment for blood pressure and cholesterol level.
c In the last 2 columns, the RRs are adjusted for systolic blood pressure (instead of other indicators such as diastolic blood pressure) and total cholesterol
concentrations (instead of other indicators of cholesterol).
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this was already no point of de-
bate). Because high blood pressure
and cholesterol levels are plausible
intermediary factors in the causal
pathways linking overweight and
CHD,6 adjusting for them—in epi-
demiological analyses—certainly re-
sults in underestimating the total
public health impact of over-
weight. Second, the fact that the RR
of CHD remained statistically sig-
nificant after adjustment for these in-
termediary factors adds to the evi-
dence that overweight itself increases
CHD risk independent of tradi-
tional risk factors. This implies that,
even under the theoretical scenario
that optimal treatment would be
available against hypertension and
hypercholesterolemia in over-
weight persons, they still would have
an elevated risk of CHD. It also im-
plies that overweight, which is eas-
ily measured, may be considered to
be incorporated as an additional risk
factor in commonly used risk strati-
fication schemes such as Adult
Treatment Panel III7 and the
Framingham CHD prediction algo-
rithm,8 even though the exact
mechanism that underlies an “inde-
pendent” effect remains to be
resolved.
The present estimate of the RR
adjusted for blood pressure and cho-
lesterol level, ie, 1.16 per 5 BMI
units, is similar to the recently re-
ported RR of hospitalization for CHD
of 1.16 per 4 BMI units after adjust-
ment for smoking, systolic blood
pressure, and total cholesterol level.9
Because hypertension is correlated
with other features of the meta-
bolic syndrome, such as fasting se-
rum glucose level,11,38 part of the re-
duction in the RR after adjustment
for blood pressure may be caused by
adjustment for these correlated vari-
ables, resulting in an overestimate of
the excess risk of CHD mediated by
blood pressure and cholesterol con-
centrations. On the other hand, the
use of a single measurement of blood
pressure and cholesterol, as op-
posed to repeated measurements,
may have underestimated the effect
of adjustment for these variables.39
Several mechanisms could un-
derlie an effect of overweight on
CHD independent of traditional risk
factors. These include a state of
low-grade inflammation, endothe-
lial dysfunction, hemostatic imbal-
ance favoring coagulation, impaired
endothelial vasodilatory responses,
left ventricular hypertrophy due to
an increased blood volume, and re-
duced heart rate variability due to
withdrawal of vagal activity and sym-
pathetic predominance.40 Obvi-
ously, overweight is associated with
increased risk of type 2 diabetes
mellitus.41 In Adult Treatment Panel
III, obesity is not listed as a risk fac-
tor because it is said to operate
through diabetes (and other risk fac-
tors).7 Therefore, inclusion of data
on diabetes or glucose intolerance in
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our analysis (which were not avail-
able for the meta-analysis) would
have further attenuated the RR of
CHD associated with overweight. In-
deed, a large Korean cohort study11
showed that the RR of death from
atherosclerotic cardiovascular causes
decreased considerably after adjust-
ment for blood pressure, choles-
terol level, and fasting blood glu-
cose level. Interestingly, the authors
stated that, in addition to these fac-
tors, other consequences of in-
creased BMI are likely to contrib-
ute to the risk of cardiovascular
disease.
Before invoking the plausible
pathways mentioned previously,
some alternative explanations for our
findings must be mentioned. There
may have been confounders for
which we were unable to adjust, and
that themselves, rather than over-
weight, determine the risk of CHD.
For instance, we did not control for
diet, which has been shown to be re-
lated to CHD,42 because detailed di-
etary data were usually not avail-
able. However, in the Nurses’ Health
Study—the largest study included—
adjustment for diet had virtually no
impact on the association between
BMI and risk of CHD.29 Also, the
possibility of residual confounding
due to inaccurate assessment of
smoking and physical activity can-
not be excluded. Despite diversity in
the assessment of physical activity,
most studies used measures that dis-
cerned between low and at least
moderate levels of activity and, in
most studies, additional adjust-
ment for physical activity did not
substantially change the age-, sex-,
and smoking-adjusted RRs substan-
tially (data not shown), which might
indicate that measurement error did
not differ much between studies.
With respect to the measure of
body fatness used, waist-to-hip ra-
tio has been shown to be more
strongly related to CHD.43,44 The
INTERHEART study demon-
strated a graded and highly signifi-
cant association between myocar-
dial infarction and waist-to-hip ratio,
in contrast to BMI.43 However, that
study had a cross-sectional case-
control design, and the long-term in-
fluence of factors such as over-
weight in midlife therefore could not
be assessed. Furthermore, BMI is by
far the most common measure of
body fatness, especially in cohort
studies that started decades ago, and
therefore is most suitable for a meta-
analysis. The present findings ap-
ply to healthy persons, predomi-
nantly white. A meta-analysis of
cohorts in the Asia-Pacific region
showed that risk of cardiovascular
disease and CHD increased linearly
from BMI levels as low as 18.45 It is
known that in Asians the risk of
CHD is increased at lower levels of
BMI than in whites46 and hence con-
firmation in primarily white popu-
lations was warranted. Our results
are similar to those of a previous sys-
tematic review47 that included
mainly white cohorts, which found
a RR of 1.14 per 2 BMI units. How-
ever, no formal meta-analysis was at-
tempted in that study, and there was
more variation between cohorts in
the covariates for which the RRs
were adjusted.
We conclude that moderate over-
weight and obesity are associated
with a significant increase in risk of
CHD, and thus that the worldwide
increase in (moderate) overweight
may drive the incidence of CHD up-
ward. Although effects of confound-
ers, such as specific dietary factors,
cannot be completely ruled out,
negative effects will be exerted both
through adverse influences on blood
pressure and cholesterol levels (ac-
counting for approximately 45% of
the increased risk) and through
other pathways.
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